Free Trial
Earnings Season Is Here. MarketBeat All Access for Just $149
Get the Deal
Claim MarketBeat All Access Sale Promotion

Johnson Matthey PLC (JMAT.L) - What Are Analysts Thinking About This Stock?

Johnson Matthey logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

Johnson Matthey PLC (LON:JMAT - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six brokerages that are covering the company, MarketBeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is GBX 2,283.33.

Several analysts have weighed in on JMAT shares. Jefferies Financial Group reaffirmed a "buy" rating and issued a GBX 2,330 price target on shares of Johnson Matthey in a report on Tuesday, August 4th. Deutsche Bank Aktiengesellschaft reissued a "buy" rating and issued a GBX 2,400 price target on shares of Johnson Matthey in a research note on Monday, July 6th.

View Our Latest Stock Analysis on Johnson Matthey

Insider Buying and Selling at Johnson Matthey

In related news, insider Liam Condon acquired 10,951 shares of the stock in a transaction on Friday, September 11th. The stock was acquired at an average cost of GBX 2,306 per share, for a total transaction of £252,530.06. Also, insider Richard Pike bought 17,635 shares of the stock in a transaction dated Friday, September 11th. The stock was purchased at an average price of GBX 2,248 per share, with a total value of £396,434.80. Over the last 90 days, insiders purchased 28,608 shares of company stock worth $64,947,512. 0.77% of the stock is currently owned by insiders.

Johnson Matthey Stock Performance

LON JMAT opened at GBX 2,418 on Tuesday. The firm has a market cap of £3.04 billion, a P/E ratio of -31.70, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.93. The company has a quick ratio of 0.76, a current ratio of 1.56 and a debt-to-equity ratio of 69.69. The company's 50 day moving average is GBX 2,326.78 and its 200-day moving average is GBX 2,141.54. Johnson Matthey has a 12-month low of GBX 2,192 and a 12-month high of GBX 3,245.33.

About Johnson Matthey

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

See Also

Analyst Recommendations for Johnson Matthey (LON:JMAT)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Johnson Matthey Right Now?

Before you consider Johnson Matthey, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.

While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines